In this pilot study, we proposed an algorithm to use thromboelastography platelet mapping
(TEG-PM) as an effective preoperative platelet function assessment tool in coronary artery …

Aim: With an increase in the number of patients who are on antiplatelet medications until the
day of surgery, we undertook a prospective observational study to assess the ability of …

In their institutional coronary artery bypass grafting (CABG) experience, they used
thromboelastographyplatelet mapping (TEG-PM) as a means to assess platelet function …

Background The management of patients on dual antiplatelet therapy (DAPT) prior to
cardiac surgery is challenging. At least 10% of patients presenting with acute coronary …

Objective: Anti-platelet therapy is associated with increased perioperative bleeding.
Although current guidelines call for its caessation 5–10 days prior to cardiac surgery, this …

Background Dual antiplatelet therapy is a key strategy to prevent thrombosis and ischemia
in patients with high risk coronary artery disease. These drugs are often irreversible …

BACKGROUND: Patients presenting with acute coronary syndrome are administered a P2Y
12 inhibitor and aspirin before coronary catheterization to prevent further myocardial injury …

Background Patients often fail to stop clopidogrel appropriately before non-cardiac surgery.
Thromboelastography platelet mapping (TEG-PM) can be used to measure the percentage …

Objective: Objective platelet function assessment after cardiac surgery can predict
postoperative blood loss, guide transfusion requirements and discriminate the need for …

Abstract Background The Society of Thoracic Surgeons current (STS) guidelines
recommend delaying coronary artery bypass graft surgery (CABG) for several days or …